PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype

SIMPLE SUMMARY: Lung cancer is the leading cause of cancer death worldwide. Most lung cancers are classified as non-small cell lung cancer (NSCLC), which is diagnosed at an advanced stage when various treatments cannot be curative. Immunotherapy is a promising treatment for many cancers, including N...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucà, Stefano, Franco, Renato, Napolitano, Antonella, Soria, Valeria, Ronchi, Andrea, Zito Marino, Federica, Della Corte, Carminia Maria, Morgillo, Floriana, Fiorelli, Alfonso, Luciano, Antonio, Palma, Giuseppe, Arra, Claudio, Battista, Sabrina, Cerchia, Laura, Fedele, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093756/
https://www.ncbi.nlm.nih.gov/pubmed/37046851
http://dx.doi.org/10.3390/cancers15072190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093756/
https://www.ncbi.nlm.nih.gov/pubmed/37046851
http://dx.doi.org/10.3390/cancers15072190

Ejemplares similares